Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Homoharringtonine and Interferon Alfa in CML
NCT00002574Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 1994
- Primary completion
- Jun 2001
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of homoharringtonine in chronic myeloid leukemia (CML), sponsored by National Cancer Institute. Started Sep 1994; status: completed.
02
Drugs
homoharringtonine
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00002574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002574.